Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 20, 2025, titled "Senores Pharmaceuticals acquires ANDA for Roflumilast 250 mcg and 500 mcg tablets".
Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 20, 2025, titled "Senores Pharmaceuticals acquires ANDA for Roflumilast 250 mcg and 500 mcg tablets".